Author

S. S. So

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

A. K.-y. Lam· 1 shared A. M. Finch· 1 shared A. W.-i. Lo· 1 shared B. C.-c. Lung· 1 shared B. P. Wilkins· 1 shared B. T.-t. Law· 1 shared C. L.-y. Wong· 1 shared C. W.-y. Wong· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. K.-y. Lam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ΔNp63-restricted viral mimicry response impedes cancer cell viability and remodels tumor microenvironment in esophageal squamous cell carcinoma

V. Z. Yu, S. S. So, B. C.-c. Lung, G. Z. Hou, C. W.-y. Wong, L. K.-y. Chow, M. K.-y. Chung, I. Y.-h. Wong, C. L.-y. Wong, D. K.-k. Chan, F. S.-y. Chan, B. T.-t. Law, K. Xu, Z. Z. Tan, K.-o. Lam, , M. L. Lung

This study identifies ΔNp63's role in restricting viral mimicry response in ESCC, reducing cell viability, and modulating tumor microenvironment immune cells.

bioRxiv · Mar 17, 2024Cancer Biology

Orphan G protein-coupled receptor, GPR37L1: pharmacological toolbox empty once again

T. Ngo, B. P. Wilkins, S. S. So, P. Keov, K. K. Chahal, A. M. Finch, J. L. J. Coleman, I. Kufareva, N. J. Smith

The paper corrects a cloning error in a 2017 study on GPR37L1 ligand discovery and reports unsuccessful re-testing of predicted ligands, leading to a retraction initiative.

bioRxiv · Sep 11, 2020 · PreprintPharmacology & Toxicology